Robuta

https://facts.net/fitness-and-wellbeing/health-science/50-facts-about-pompes-disease/
Pompe's Disease is a rare genetic disorder that affects the body's ability to break down glycogen, a complex sugar stored in muscles and liver. This con
factspompediseasenet
https://www.pharmaceutical-technology.com/news/aro-biotherapeutics-pompe-disease/
Aro Biotherapeutics has raised $41.5m in a Series B financing round to advance the development of ABX1100 for Pompe disease.
pompe diseasearobiotherapeuticsraisesfunds
https://www.sanofi.com/fr/media-room/communiques-de-presse/2021/2021-07-27-17-23-10-2269762
Sanofi provides update on avalglucosidase alfa EU submission for patients with Pompe Disease July 27, 2021 The European Medicines Agency's (EMA) Committee for...
avalglucosidase alfasanofiprovidesupdateeu
https://pubmed.ncbi.nlm.nih.gov/31076647/
A newborn screening program for Pompe disease using dried blood spots (DBSs) was initiated in Japan. Here, we summarized this screening program and described...
newborn screeningpompe diseasejapanreportliterature
https://pompediscussiondriver.com/
An interactive guide to help you outline your Pompe symptoms and organize your thoughts for a more productive discussion with your healthcare provider.
pompe diseasedoctordiscussiondrivercreate
https://pompe.community/
Pompe.Community, architected by Pompe Consortium, is a virtual town square for those who have been impacted by or are interested in Pompe Disease.
town squarepompecommunitydiseaseeveryone
https://www.sanofi.com/en/media-room/press-releases/2021/2021-07-27-17-23-10-2269762
Sanofi provides update on avalglucosidase alfa EU submission for patients with Pompe Disease July 27, 2021 The European Medicines Agency's (EMA) Committee for...
avalglucosidase alfasanofiprovidesupdateeu
https://www.sanofi.com/en/media-room/press-releases/2020/2020-11-18-06-00-00-2128825
FDA grants priority review for...
priority reviewavalglucosidase alfafdagrantspotential